|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
|
|---|---|---|---|---|---|---|---|---|---|
| Cash and cash equivalents | |||||||||
| Receivables, prepaids and deposits | |||||||||
| Total current assets | |||||||||
| Investment in Green Technology Metals | |||||||||
| Investment in Ascend Elements | |||||||||
| Restricted cash | |||||||||
| Property, plant and equipment | |||||||||
| Other assets | |||||||||
| Exploration and evaluation assets | |||||||||
| Total non-current assets | |||||||||
| TOTAL ASSETS | |||||||||
| Accounts payable and accrued liabilities | |||||||||
| Current portion of long-term liabilities | |||||||||
| GM transaction derivative liability | |||||||||
| Loan from former parent | |||||||||
| Total current liabilities | |||||||||
| Other liabilities | |||||||||
| Decommissioning provision | |||||||||
| Total Long-term liabilities | |||||||||
| TOTAL LIABILITIES | |||||||||
| Share capital | |||||||||
| Contributed surplus and net former parent investment | |||||||||
| Deficit | |||||||||
| TOTAL SHAREHOLDERS' EQUITY | |||||||||
| TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY | |||||||||
| ASSETS | |||||||||
| Cash (Note 2) | |||||||||
| Restricted cash (Note 2) | |||||||||
| Receivables | |||||||||
| Prepaids and deposits | |||||||||
| Total current assets | |||||||||
| Investments measured at fair value (Note 16) | |||||||||
| Restricted cash | |||||||||
| Mineral properties, plant and equipment, net (Note 3) | |||||||||
| Deferred financing costs (Note 4) | |||||||||
| Other assets | |||||||||
| Total assets | |||||||||
| LIABILITIES | |||||||||
| Accounts payable | |||||||||
| Accrued liabilities (Note 6) | |||||||||
| Current portion of lease liabilities (Note 7) | |||||||||
| GM Tranche 2 liability (Note 4) | |||||||||
| Total current liabilities | |||||||||
| Convertible debt and conversion feature (Note 8) | |||||||||
| Convertible debt measured at fair value (Note 9) | |||||||||
| Warrant obligation (Note 4) | |||||||||
| LAC Warrants | |||||||||
| JV Warrants | |||||||||
| Total warrant obligation (Note 4) | |||||||||
| DOE Loan (Note 4) | |||||||||
| Royalty and production payment arrangements (Note 8) | |||||||||
| Lease liabilities (Note 7) | |||||||||
| Reclamation liabilities | |||||||||
| Other liabilities (Note 7) | |||||||||
| Total liabilities | |||||||||
| Non-controlling interest (Note 5) | |||||||||
| STOCKHOLDERS' EQUITY | |||||||||
| Common stock, no par value, unlimited authorized; 377,335 and 314,335 shares issued and outstanding as of September 30, 2026 and December 31, 2025, respectively (Note 10) | |||||||||
| Additional paid-in capital | |||||||||
| Accumulated deficit | |||||||||
| Total stockholders' equity | |||||||||
| Total liabilities, non-controlling interest and stockholders' equity |
Loading...